Psyched Wellness Ltd (CSE:PSYC, OTCQB:PSYCF) Ltd CEO Jeff Stevens tells Proactive's Stephen Gunnion the company is preparing to move to commercialization of its Amanita Muscaria formulation following the move from R&D to pre-sales, which have just closed.
"We've had incredibly great, positive feedback from our pilot run; from the 300 samples that we did which allowed us to then pick the final flavor formulation and move towards commercialisation," he said.
Stevens also expanded on news that the company has strengthened its IP portfolio by updating its existing provisional patent on its Amanita Muscaria extract AME-1 and filing a US provisional patent for Amanita Muscaria material, extract, and compounds in vaporizer formulations and devices with the US Patent and Trademark Office.
#ProactiveInvestors #PsychedWellness #AmanitaMuscaria #CSE #OTCQB